BioLife Solutions (BLFS) Appoints Timothy L. Moore to its Board

Go back to BioLife Solutions (BLFS) Appoints Timothy L. Moore to its Board

BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors

August 25, 2022 8:03 AM UTC

Industry veteran brings extensive technical operations scale-up experience and extreme fluency in cell therapy tools and services selection process

BOTHELL, Wash., Aug. 25, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies ("CGT") and the broader biopharma markets, today announced the appointment of Timothy L. Moore to its board of... More